{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:31:24Z","timestamp":1783913484545,"version":"3.55.0"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["APP1044624"],"award-info":[{"award-number":["APP1044624"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.phrs.2016.02.011","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T15:40:55Z","timestamp":1455637255000},"page":"51-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications"],"prefix":"10.1016","volume":"106","author":[{"given":"Jiamei","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagesh","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.02.011_bib0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4088\/JCP.10r06264yel","article-title":"Past and present progress in the pharmacologic treatment of schizophrenia","volume":"71","author":"Kane","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0010","first-page":"171","article-title":"Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management","volume":"5","author":"Krill","year":"2014","journal-title":"Adolesc. Health Med. Ther."},{"key":"10.1016\/j.phrs.2016.02.011_bib0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.18773\/austprescr.2011.057","article-title":"Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis","volume":"34","author":"Lambert","year":"2011","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.phrs.2016.02.011_bib0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.phrs.2016.02.011_bib0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ejcn.2013.253","article-title":"The effects of second-generation antipsychotics on food intake: resting energy expenditure and physical activity","volume":"68","author":"Cuerda","year":"2014","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2016.02.011_bib0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ecl.2013.05.006","article-title":"Effects of antipsychotic medications on appetite weight, and insulin resistance","volume":"42","author":"Deng","year":"2013","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.phrs.2016.02.011_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1874205X01307010023","article-title":"Antipsychotic drugs opposite to metabolic risk: neurotransmitters: neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndrome","volume":"7","author":"Milano","year":"2013","journal-title":"Open Neurol. J."},{"key":"10.1016\/j.phrs.2016.02.011_bib0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","article-title":"Antipsychotic drugs and obesity","volume":"17","author":"Correll","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2016.02.011_bib0045","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/0269881110368872","article-title":"Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics","volume":"25","author":"Osuntokun","year":"2011","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0253-7176.127244","article-title":"Adherence and continuation of treatment with first- and second-generation antipsychotics in schizophrenia","volume":"36","author":"Warikoo","year":"2014","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.phrs.2016.02.011_bib0055","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.psyneuen.2012.09.009","article-title":"Schizophrenia: metabolic aspects of aetiology: diagnosis and future treatment strategies","volume":"38","author":"Harris","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2009.11.009","article-title":"The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain","volume":"34","author":"Deng","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.phrs.2016.02.011_bib0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40263-013-0062-1","article-title":"The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain","volume":"27","author":"He","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2016.02.011_bib0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-Histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S1516-44462011000200005","article-title":"The effectiveness of a non-pharmacological intervention for weight gain management in severe mental disorders: results from a national multicentric study","volume":"33","author":"Attux","year":"2011","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.phrs.2016.02.011_bib0080","doi-asserted-by":"crossref","unstructured":"G. Faulkner, T.A. Cohn, Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications.[erratum appears in Can J Psychiatry. 2006 Aug; 51 (9): 620]. Canadian Journal of Psychiatry \u2212 Revue Canadienne de Psychiatrie 51 (2006) 502-511.","DOI":"10.1177\/070674370605100805"},{"key":"10.1016\/j.phrs.2016.02.011_bib0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/157340012798994867","article-title":"Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers","volume":"8","author":"Fiedorowicz","year":"2012","journal-title":"Curr. Psychiatry Rev."},{"key":"10.1016\/j.phrs.2016.02.011_bib0090","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00023210-200822060-00003","article-title":"Pharmacological management of atypical antipsychotic-induced weight gain","volume":"22","author":"Baptista","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2016.02.011_bib0095","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/npp.2010.21","article-title":"Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis","volume":"35","author":"Maayan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0100","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1176\/appi.ajp.2013.12010127","article-title":"Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder","volume":"170","author":"Jarskog","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1176\/appi.ajp.159.4.655","article-title":"Metformin for weight loss in pediatric patients taking psychotropic drugs","volume":"159","author":"Morrison","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/cap.2008.094","article-title":"Metformin for weight control in pediatric patients on atypical antipsychotic medication","volume":"19","author":"Shin","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/cap.2010.2022","article-title":"Use of metformin to control clozapine-associated weight gain in an adolescent with schizoaffective disorder","volume":"20","author":"Weaver","year":"2010","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0120","doi-asserted-by":"crossref","first-page":"e93310","DOI":"10.1371\/journal.pone.0093310","article-title":"Metformin and berberine prevent olanzapine-induced weight gain in rats","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.02.011_bib0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0028-1085438","article-title":"Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind placebo-controlled, 12-week trial","volume":"42","author":"Baptista","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0130","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4088\/JCP.09m05274yel","article-title":"The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis","volume":"71","author":"Ehret","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/YIC.0000000000000022","article-title":"Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophrenia","volume":"29","author":"Biedermann","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0140","first-page":"225","article-title":"Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments","volume":"24","author":"Das","year":"2012","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/jc.2014-3421","article-title":"Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis","volume":"100","author":"Domecq","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.02.011_bib0150","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1310\/hpj4904-345","article-title":"Topiramate: antipsychotic-induced weight gain","volume":"49","author":"Generali","year":"2014","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.phrs.2016.02.011_bib0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2013.03.021","article-title":"The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized double-blind, placebo-controlled clinical trial","volume":"147","author":"Ghanizadeh","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.phrs.2016.02.011_bib0160","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbu030","article-title":"Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis","author":"Mizuno","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.phrs.2016.02.011_bib0165","first-page":"1","article-title":"The histaminergic system as a target for the prevention of obesity and metabolic syndrome","author":"Provensi","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0170","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2016.02.011_bib0175","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.2174\/092986710794182944","article-title":"Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity","volume":"17","author":"Masaki","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2016.02.011_bib0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000095339","article-title":"Increased susceptibility to diet-induced obesity in histamine-deficient mice","volume":"83","author":"Jorgensen","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0185","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The physiology of brain histamine","volume":"63","author":"Brown","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tips.2006.03.008","article-title":"The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity","volume":"27","author":"Masaki","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0195","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1046\/j.1460-9568.1998.00240.x","article-title":"Postnatal expression of H1-receptor mRNA in the rat brain: correlation to L-histidine decarboxylase expression and local upregulation in limbic seizures","volume":"10","author":"Lintunen","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0200","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor","volume":"302","author":"Arrang","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.02.011_bib0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2008.11.018","article-title":"Localization of histamine H4 receptors in the central nervous system of human and rat","volume":"1250","author":"Strakhova","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2016.02.011_bib0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/jpet.110.171306","article-title":"The histamine H3 receptor and eating behavior","volume":"336","author":"Passani","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.02.011_bib0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0006-8993(99)02055-7","article-title":"Increased binding at 5-HT1A 5-HT1B, and 5-HT2A receptors and 5-HT transporters in diet-induced obese rats","volume":"847","author":"Park","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2016.02.011_bib0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuroscience.2012.04.068","article-title":"Loss of histaminergic modulation of thermoregulation and energy homeostasis in obese mice","volume":"217","author":"Sethi","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.02.011_bib0225","first-page":"288","article-title":"Histamine: intraventricular injection suppresses ingestive behavior of the cat","volume":"206","author":"Clineschmidt","year":"1973","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.phrs.2016.02.011_bib0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0031-9384(88)90142-4","article-title":"Changes in the feeding behavior of rats elicited by histamine infusion","volume":"44","author":"Itowi","year":"1988","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2016.02.011_bib0235","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-8993(98)00186-3","article-title":"Effects of intracerebroventricularly infused histamine and selective H1: H2 and H3 agonists on food and water intake and urine flow in Wistar rats","volume":"793","author":"Lecklin","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2016.02.011_bib0240","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1210\/en.2003-0222","article-title":"Hyperleptinemia visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene","volume":"144","author":"Fulop","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0245","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2353\/ajpath.2010.091198","article-title":"Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice","volume":"177","author":"Wang","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0250","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/FBP.0b013e3282f62c66","article-title":"Comparative effects of olanzapine and ziprasidone on hypophagia induced by enhanced histamine neurotransmission in the rat","volume":"19","author":"Davoodi","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0255","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.2337\/diabetes.53.9.2250","article-title":"Involvement of hypothalamic histamine H1 Receptor in the regulation of feeding rhythm and obesity","volume":"53","author":"Masaki","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.02.011_bib0260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2007.11.055","article-title":"Histamine depolarizes neurons in the dorsal vagal complex","volume":"432","author":"Poole","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2016.02.011_bib0265","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors","volume":"374","author":"Tecott","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.02.011_bib0270","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diabetes.50.2.385","article-title":"Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding adiposity, and UCP family in mice","volume":"50","author":"Masaki","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.02.011_bib0275","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1358\/mf.2010.32.10.1545781","article-title":"Innervation of histamine neurons in the caudal part of the arcuate nucleus of hypothalamus and their activation in response to food deprivation under scheduled feeding","volume":"32","author":"Umehara","year":"2010","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0280","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psyneuen.2014.01.018","article-title":"Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats","volume":"42","author":"He","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0285","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2010.04.008","article-title":"Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design","volume":"127","author":"Coccurello","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.02.011_bib0290","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09540260801889179","article-title":"Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients","volume":"20","author":"Correll","year":"2008","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0295","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2133\/dmpk.20.368","article-title":"Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus","volume":"20","author":"Matsui-Sakata","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.phrs.2016.02.011_bib0300","first-page":"459284","article-title":"Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies","volume":"2011","author":"Panariello","year":"2011","journal-title":"Schizophr. Res. Treat."},{"key":"10.1016\/j.phrs.2016.02.011_bib0305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0447.2008.01334.x","article-title":"Which comes first: atypical antipsychotic treatment or cardiometabolic risk","volume":"119","author":"Stahl","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.phrs.2016.02.011_bib0310","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.psyneuen.2008.01.018","article-title":"Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression","volume":"33","author":"Han","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0315","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phrs.2016.02.011_bib0320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.06.010","article-title":"Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic: nPY and AMPK pathways","volume":"48","author":"Lian","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0325","doi-asserted-by":"crossref","first-page":"e104160","DOI":"10.1371\/journal.pone.0104160","article-title":"Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment","volume":"9","author":"Lian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.02.011_bib0330","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-011-2211-x","article-title":"Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication","volume":"216","author":"Vehof","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0335","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14205\/2312-3710.2014.01.01.3","article-title":"Mechanisms of increased appetite and weight gain induced by psychotropic medications","volume":"1","author":"WysokinskiI","year":"2014","journal-title":"J. Adv. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0340","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0006-3223(98)00100-0","article-title":"Novel antipsychotics and new onset diabetes","volume":"44","author":"Erhart","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0345","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v60n0602","article-title":"Novel antipsychotics: comparison of weight gain liabilities","volume":"60","author":"Wirshing","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0350","first-page":"109","article-title":"Once daily loratadine versus astemizole once daily","volume":"73","author":"Chervinsky","year":"1994","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.phrs.2016.02.011_bib0355","first-page":"213","article-title":"Ingestive behavior and composition of weight change during cyproheptadine administration","volume":"3","author":"Saleh","year":"1979","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2016.02.011_bib0360","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/MPG.0000000000000467","article-title":"Use of cyproheptadine in young children with feeding difficulties and poor growth in a pediatric feeding program","volume":"59","author":"Sant'Anna","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.phrs.2016.02.011_bib0365","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00421472","article-title":"The effect of cyproheptadine on hunger: calorie intake and body weight in man","volume":"40","author":"Silverstone","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.phrs.2016.02.011_bib0370","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","article-title":"Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat","volume":"219","author":"Jassim","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0375","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.phrs.2015.07.023","article-title":"Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKalpha-SREBP-1 and PPARalpha-dependent pathways","volume":"100","author":"Liu","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2016.02.011_bib0380","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1523\/JNEUROSCI.0378-10.2010","article-title":"Histamine influences body temperature by acting at H1 and H3 receptors on distinct populations of preoptic neurons","volume":"30","author":"Lundius","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0385","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.physbeh.2011.05.033","article-title":"Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism","volume":"104","author":"Teff","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2016.02.011_bib0390","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1038\/nrn3526","article-title":"The histaminergic network in the brain: basic organization and role in disease","volume":"14","author":"Panula","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0395","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0306-4522(02)00135-5","article-title":"A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain","volume":"114","author":"Pillot","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.02.011_bib0400","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI15784","article-title":"Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype","volume":"110","author":"Takahashi","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.02.011_bib0405","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1523\/JNEUROSCI.2690-04.2004","article-title":"Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata","volume":"24","author":"Threlfell","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0410","doi-asserted-by":"crossref","unstructured":"E. SchlickerI. Marr. The moderate affinity of clozapine at H<sub>3<\/sub> receptors is not shared by its two major metabolites and by structurally related and unrelated atypical neuroleptics. Naunyn Schmiedebergs Arch Pharmacol, 353 (1996) 290-294.","DOI":"10.1007\/BF00168630"},{"key":"10.1016\/j.phrs.2016.02.011_bib0415","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnsys.2012.00072","article-title":"Histamine H3 receptor antagonists\/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease ADHD, schizophrenia, and drug abuse","volume":"6","author":"Vohora","year":"2012","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0420","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1124\/mol.61.1.239","article-title":"Presynaptic H3 autoreceptors modulate histamine synthesis through cAMP pathway","volume":"61","author":"Gomez-Ramirez","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0425","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainresbull.2008.12.012","article-title":"Acute central administration of immepip a histamine H3 receptor agonist, suppresses hypothalamic histamine release and elicits feeding behavior in rats","volume":"79","author":"Chiba","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2016.02.011_bib0430","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2011.04.003","article-title":"Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system","volume":"61","author":"Murotani","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0435","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neulet.2011.05.060","article-title":"AMP-activated protein kinase activates neuropeptide Y neurons in the hypothalamic arcuate nucleus to increase food intake in rats","volume":"499","author":"Kohno","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2016.02.011_bib0440","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature02440","article-title":"AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus","volume":"428","author":"Minokoshi","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.02.011_bib0445","doi-asserted-by":"crossref","first-page":"18933","DOI":"10.1074\/jbc.M512831200","article-title":"Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle","volume":"281","author":"Martin","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.02.011_bib0450","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism","volume":"1","author":"Kahn","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.02.011_bib0455","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2826.2008.01745.x","article-title":"Role of AMP-activated protein kinase in the control of appetite","volume":"20","author":"Kola","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0460","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.molmed.2008.09.007","article-title":"AMPK: a metabolic gauge regulating whole-body energy homeostasis","volume":"14","author":"Lage","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2016.02.011_bib0465","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.2337\/db12-1451","article-title":"Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin","volume":"62","author":"Ram\u00edrez","year":"2013","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2016.02.011_bib0470","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2009.05916.x","article-title":"AMPK in the brain: its roles in energy balance and neuroprotection","volume":"109","author":"Ronnett","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2016.02.011_bib0475","doi-asserted-by":"crossref","first-page":"e36185","DOI":"10.1371\/journal.pone.0036185","article-title":"Desipramine inhibits histamine H1 receptor-induced Ca2+ signaling in rat hypothalamic cells","volume":"7","author":"Kang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.02.011_bib0480","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10571-011-9663-8","article-title":"A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats","volume":"31","author":"Sejima","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0485","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145713000862","article-title":"Olanzapine depot formulation in rat: A step forward in modelling antipsychotic-induced metabolic adverse effects","volume":"17","author":"Skrede","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0490","doi-asserted-by":"crossref","first-page":"e20571","DOI":"10.1371\/journal.pone.0020571","article-title":"Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation","volume":"6","author":"Fern\u00f8","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.02.011_bib0495","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.2337\/db10-0449","article-title":"Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance","volume":"59","author":"Martins","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.02.011_bib0500","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psyneuen.2012.06.012","article-title":"The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: olanzapine monotherapy","volume":"38","author":"Ak","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0505","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2014.03.003","article-title":"The hypothalamic arcuate nucleus and the control of peripheral substrates","volume":"28","author":"Joly-Amado","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.02.011_bib0510","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fendo.2014.00058","article-title":"Peptides and food intake","volume":"5","author":"Sobrino Crespo","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0515","doi-asserted-by":"crossref","DOI":"10.1186\/1743-7075-11-27","article-title":"Hypothalamus-adipose tissue crosstalk: Neuropeptide y and the regulation of energy metabolism","volume":"11","author":"Zhang","year":"2014","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0520","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/oby.2005.73","article-title":"Neuropeptides, including neuropeptide Y and melanocortins: mediate lipolysis in murine adipocytes","volume":"13","author":"Bradley","year":"2005","journal-title":"Obes. Res."},{"key":"10.1016\/j.phrs.2016.02.011_bib0525","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","article-title":"Therapeutic potential of neuropeptide Y (NPY) receptor ligands","volume":"2","author":"Brothers","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2016.02.011_bib0530","first-page":"743","article-title":"Evolution of neuropeptide Y and its related peptides","volume":"106","author":"Larhammar","year":"1993","journal-title":"Comp. Biochem. Physiol. C"},{"key":"10.1016\/j.phrs.2016.02.011_bib0535","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1074248413501017","article-title":"New and emerging drug molecules against obesity","volume":"19","author":"George","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.02.011_bib0540","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.drudis.2013.08.015","article-title":"Central nervous system biomarkers for antiobesity drug development","volume":"18","author":"Ziauddeen","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2016.02.011_bib0545","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0196-9781(93)90135-4","article-title":"Feeding responses to perifornical hypothalamic injection of neuropeptide Y in relation to circadian rhythms of eating behavior","volume":"14","author":"Stanley","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.phrs.2016.02.011_bib0550","first-page":"824305","article-title":"Obesity and appetite control","author":"Suzuki","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.phrs.2016.02.011_bib0555","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.peptides.2004.02.006","article-title":"Hypothalamic control of energy balance: different peptides different functions","volume":"25","author":"Leibowitz","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.phrs.2016.02.011_bib0560","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.yfrne.2011.06.001","article-title":"The role of NPY in hypothalamic mediated food intake","volume":"32","author":"Mercer","year":"2011","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0565","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-11-27","article-title":"Hypothalamus-adipose tissue crosstalk: neuropeptide Y and the regulation of energy metabolism","volume":"11","author":"Zhang","year":"2014","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.phrs.2016.02.011_bib0570","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.npep.2012.09.004","article-title":"Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding","volume":"46","author":"Kohno","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.phrs.2016.02.011_bib0575","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1152\/physrev.00015.2004","article-title":"Hormonal regulation of food intake","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2016.02.011_bib0580","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ilar.53.1.35","article-title":"Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use","volume":"53","author":"Barson","year":"2012","journal-title":"ILAR J."},{"key":"10.1016\/j.phrs.2016.02.011_bib0585","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1073\/pnas.95.25.15043","article-title":"The neuropeptide Y\/agouti gene-related protein (AGRP) brain circuitry in normal anorectic, and monosodium glutamate-treated mice","volume":"95","author":"Broberger","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.02.011_bib0590","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn1455","article-title":"Anatomy and regulation of the central melanocortin system","volume":"8","author":"Cone","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0595","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1210\/endo.140.3.6544","article-title":"Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat","volume":"140","author":"Haskell-Luevano","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0600","first-page":"164","article-title":"AgRP (83\u2013132) acts as an inverse agonist on the human-melanocortin-4 receptor","volume":"15","author":"Nijenhuis","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0605","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ajmg.a.20600","article-title":"Ala67Thr polymorphism in the Agouti-related peptide gene is associated with inherited leanness in humans","volume":"126A","author":"Marks","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.phrs.2016.02.011_bib0610","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2310\/JIM.0b013e3181bb0d49","article-title":"Central leptin receptor action and resistance in obesity","volume":"57","author":"Bj\u00f8rb\u00e6k","year":"2009","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.phrs.2016.02.011_bib0615","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.278.5335.135","article-title":"Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein","volume":"278","author":"Ollmann","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.02.011_bib0620","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1101\/gad.11.5.593","article-title":"Hypothalamic expression of ART a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice","volume":"11","author":"Shutter","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2016.02.011_bib0625","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1152\/ajpregu.2000.279.1.R47","article-title":"Long-term orexigenic effects of AgRP-(83\u2013-132) involve mechanisms other than melanocortin receptor blockade","volume":"279","author":"Hagan","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0630","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.02.011_bib0635","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/nn1548","article-title":"Agouti-related peptide-expressing neurons are mandatory for feeding","volume":"8","author":"Gropp","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0640","doi-asserted-by":"crossref","first-page":"e33548","DOI":"10.1371\/journal.pone.0033548","article-title":"Alterations to melanocortinergic GABAergic and cannabinoid neurotransmission associated with olanzapine","volume":"7","author":"Weston-Green","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.02.011_bib0645","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S1461145713001697","article-title":"Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats","volume":"17","author":"Zhang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0650","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1017\/S1461145711001556","article-title":"Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response","volume":"15","author":"Nikisch","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0655","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0269881106061199","article-title":"Clozapine but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus","volume":"20","author":"Kirk","year":"2006","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0660","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/JCP.0b013e318270e5c5","article-title":"Trajectories of agouti-related protein and leptin levels during antipsychotic-associated weight gain in patients with schizophrenia","volume":"32","author":"Ehrlich","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0665","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.mp.4001944","article-title":"Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients","volume":"12","author":"Ruano","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0670","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JCP.0b013e31827d145a","article-title":"Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients","volume":"33","author":"Tiwari","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0675","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000090982","article-title":"Histaminergic neurons are involved in the orexigenic effect of orexin-A","volume":"82","author":"Jorgensen","year":"2005","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0680","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.ijo.0801915","article-title":"The NPY\/AgRP neuron and energy homeostasis","volume":"25","author":"MortonM.W. Schwartz","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.phrs.2016.02.011_bib0685","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1152\/physrev.2000.80.3.979","article-title":"Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress","volume":"80","author":"Slominski","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2016.02.011_bib0690","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2230.2006.02128.x","article-title":"Pro-opiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors","volume":"31","author":"Millington","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0695","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2011.00041","article-title":"Melanocortin receptors as novel effectors of macrophage responses in inflammation","volume":"2","author":"Patel","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0700","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnana.2015.00040","article-title":"Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons","volume":"9","author":"Wang","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.phrs.2016.02.011_bib0705","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tem.2004.10.007","article-title":"The electrophysiology of feeding circuits","volume":"15","author":"Jobst","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.02.011_bib0710","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.2337\/diabetes.54.8.2492","article-title":"Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution: a family study","volume":"54","author":"Baker","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.02.011_bib0715","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2010.10.112","article-title":"Association study of POMC variants with body composition measures and nutrient choice","volume":"660","author":"Ternouth","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0720","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/12506","article-title":"Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin","volume":"5","author":"Yaswen","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.02.011_bib0725","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1523\/JNEUROSCI.19-06-02362.1999","article-title":"Role of the CNS melanocortin system in the response to overfeeding","volume":"19","author":"Hagan","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0730","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1743-7075-4-18","article-title":"The role of proopiomelanocortin (POMC) neurones in feeding behaviour","volume":"4","author":"Millington","year":"2007","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.phrs.2016.02.011_bib0735","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"\u200ePharmacol. Ther"},{"key":"10.1016\/j.phrs.2016.02.011_bib0740","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.1074\/jbc.M109.079590","article-title":"Enhanced hypothalamic leptin signaling in mice lacking dopamine D2 receptors","volume":"285","author":"Kim","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.02.011_bib0745","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(89)91668-5","article-title":"Regulation of alpha-melanocyte-stimulating hormone release from superfused slices of rat hypothalamus by serotonin and the interaction of serotonin with the dopaminergic system inhibiting peptide release","volume":"503","author":"Tiligada","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2016.02.011_bib0750","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1124\/jpet.105.091512","article-title":"The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction","volume":"320","author":"Vicentic","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.02.011_bib0755","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1440-1681.2011.05642.x","article-title":"Roles of cocaine- and amphetamine-regulated transcript in the central nervous system","volume":"39","author":"Zhang","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0760","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-1119(96)88651-3","article-title":"Characterization of the human cDNA and genomic DNA encoding CART: a cocaine- and amphetamine-regulated transcript","volume":"169","author":"Douglass","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.phrs.2016.02.011_bib0765","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/29993","article-title":"Hypothalamic CART is a new anorectic peptide regulated by leptin","volume":"393","author":"Kristensen","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.02.011_bib0770","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ijo.2010.231","article-title":"Central regulation of feeding behavior during social isolation of rat: evidence for the role of endogenous CART system","volume":"35","author":"Nakhate","year":"2011","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2016.02.011_bib0775","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1590\/S0004-27302009000200002","article-title":"Hypothalamic regulation of food intake and clinical therapeutic applications","volume":"53","author":"Simpson","year":"2009","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0780","first-page":"29","article-title":"The main effect of cocaine- and amphetamine-regulated transcript (CART) peptide on hypothalamic neuronal activity depends on the nutritional state of rats","volume":"26","author":"Davidowa","year":"2005","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.phrs.2016.02.011_bib0785","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.neuron.2006.09.009","article-title":"Leptin in energy balance and reward: two faces of the same coin?[comment]","volume":"51","author":"Cota","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2016.02.011_bib0790","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/ijo.2009.67","article-title":"The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation","volume":"33","author":"Di Marzo","year":"2009","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2016.02.011_bib0795","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.ijo.0801863","article-title":"Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55\u2013102): effects on body weight homeostasis in lean and high-fat-fed obese rats","volume":"26","author":"Rohner-Jeanrenaud","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.phrs.2016.02.011_bib0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-9338(13)77354-1","article-title":"The role of central neuropeptides in weight gain caused by olanzapine","volume":"28","author":"Sezlev","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0805","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnins.2013.00036","article-title":"Serotonin and the regulation of mammalian energy balance","volume":"7","author":"Donovan","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0810","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/15622975.2013.858827","article-title":"Investigation of melanocortin system gene variants in antipsychotic-induced weight gain","volume":"15","author":"Chowdhury","year":"2014","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0815","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archgenpsychiatry.2012.191","article-title":"Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-Induced weight gain","volume":"69","author":"Malhotra","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0820","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0024-3205(98)00295-1","article-title":"Evidence for hypernociception induction following histamine H1 receptor activation in rodents","volume":"63","author":"Malmberg-Aiello","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2016.02.011_bib0825","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/00002018-200629110-00004","article-title":"Betahistine: a retrospective synopsis of safety data","volume":"29","author":"Jeck-Thole","year":"2006","journal-title":"Drug Saf."},{"key":"10.1016\/j.phrs.2016.02.011_bib0830","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2007.04.052","article-title":"Histaminergic ligands improve vestibular compensation in the cat: behavioural: neurochemical and molecular evidence","volume":"568","author":"Tighilet","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0835","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/13543784.17.5.795","article-title":"Betahistine: what's new on the agenda","volume":"17","author":"Barak","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.phrs.2016.02.011_bib0840","first-page":"701","article-title":"Betahistine inhibits food intake in rats","volume":"53","author":"Szelag","year":"2001","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0845","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/0269881112449396","article-title":"Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model","volume":"26","author":"Deng","year":"2012","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0850","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.02.011_bib0855","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/ijo.2008.135","article-title":"Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial","volume":"32","author":"Barak","year":"2008","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2016.02.011_bib0860","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3945\/ajcn.110.001586","article-title":"Acute effects of betahistine hydrochloride on food intake and appetite in obese women: a randomized, placebo-controlled trial","volume":"92","author":"Ali","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2016.02.011_bib0865","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00004850-200503000-00007","article-title":"The effect of betahistine a histamine H1 receptor agonist\/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients","volume":"20","author":"Poyurovsky","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0870","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00213-012-2935-2","article-title":"Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine\u2013betahistine combination","volume":"226","author":"Poyurovsky","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0875","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00213-007-0731-1","article-title":"Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study","volume":"192","author":"Poyurovsky","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0880","unstructured":"N. Barak, Y. Beck, Betahistine safely mitigates olanzapine induced weight gain and sleepiness, Collegium Internationale Neuro-Psychopharmacoloicum XXVII World Congress, Vol. 13, Hongkong, China, 2010, p. 87."},{"key":"10.1016\/j.phrs.2016.02.011_bib0885","unstructured":"L. Maayan, The attenuation of second generation antipsychotic induced weight gain in adolescents and young adults using betahistine: a double-blind, placebo-controlled trial. http:\/\/www.clinicalconnection.com\/exp\/EPVS.aspx?studyID=258108&slID=1439477 (accessed 30.06.15)."},{"key":"10.1016\/j.phrs.2016.02.011_bib0890","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1210\/en.2014-1326","article-title":"Olanzapine-activated AMPK signaling in the dorsal vagal complex is attenuated by histamine H1 receptor agonistin female rats","volume":"155","author":"He","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2016.02.011_bib0895","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1073\/pnas.0700090104","article-title":"Illuminating the molecular basis for some antipsychotic drug-induced metabolic burden","volume":"104","author":"Meltzer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phrs.2016.02.011_bib0900","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/oby.2008.468","article-title":"The role of thermogenesis in antipsychotic drug-induced weight gain","volume":"17","author":"Stefanidis","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.phrs.2016.02.011_bib0905","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cmet.2008.03.006","article-title":"Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin","volume":"7","author":"Lopez","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.02.011_bib0910","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0006-3223(98)00044-4","article-title":"Thioperamide, a histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats","volume":"45","author":"Itoh","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0915","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.peptides.2005.02.028","article-title":"The neuronal histamine H1 and pro-opiomelanocortin-melanocortin 4 receptors: independent regulation of food intake and energy expenditure","volume":"27","author":"Yoshimatsu","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.phrs.2016.02.011_bib0920","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nm.2207","article-title":"Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance","volume":"16","author":"Lopez","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.02.011_bib0925","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.cmet.2014.02.007","article-title":"Central neural regulation of brown adipose tissue thermogenesis and energy expenditure","volume":"19","author":"Morrison","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.02.011_bib0930","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/oby.20605","article-title":"Evidence for the role of AMPK in regulating PGC-1 alpha expression and mitochondrial proteins in mouse epididymal adipose tissue","volume":"22","author":"Wan","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0935","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pnpbp.2014.02.003","article-title":"Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats","volume":"51","author":"Zhang","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.phrs.2016.02.011_bib0940","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2016.02.011_bib0945","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0950","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/0269881106072750","article-title":"Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients","volume":"21","author":"Bozina","year":"2007","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0955","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/17425255.2011.532787","article-title":"Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction","volume":"7","author":"Zhang","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0960","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-642-25761-2_2","article-title":"Role of dopamine D2 receptors for antipsychotic activity","volume":"212","author":"Ginovart","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.phrs.2016.02.011_bib0965","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1755-5949.2010.00162.x","article-title":"All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors","volume":"17","author":"Seeman","year":"2011","journal-title":"CNS Neurosc. Ther."},{"key":"10.1016\/j.phrs.2016.02.011_bib0970","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0975","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2013.08.005","article-title":"Effects of olanzapine and betahistine co-treatment on serotonin transporter: 5-HT2A and dopamine D2 receptor binding density","volume":"47","author":"Lian","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.phrs.2016.02.011_bib0980","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pnpbp.2014.08.006","article-title":"Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D(2) but not 5-HT2A\/2C bindings in rat brains","volume":"56","author":"Lian","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib0985","first-page":"199","article-title":"Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis","volume":"vol. 172","author":"Kuroki","year":"2008"},{"key":"10.1016\/j.phrs.2016.02.011_bib0990","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-002-1016-3","article-title":"Long-term effects of olanzapine risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions","volume":"161","author":"Tarazi","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.phrs.2016.02.011_bib0995","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.pnpbp.2005.03.019","article-title":"The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment","volume":"29","author":"Reynolds","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.02.011_bib1000","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0022-3565(24)29589-6","article-title":"Long-term effects of olanzapine risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment","volume":"297","author":"Tarazi","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.02.011_bib1005","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","article-title":"Breakthrough dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time","volume":"27","author":"Samaha","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.02.011_bib1010","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2165\/00023210-200115110-00004","article-title":"Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action","volume":"15","author":"Lacour","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2016.02.011_bib1015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/phrs.2000.0795","article-title":"Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents","volume":"43","author":"Fossati","year":"2001","journal-title":"Pharmacol. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816300408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816300408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:53:18Z","timestamp":1748778798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816300408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":203,"alternative-id":["S1043661816300408"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.02.011","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}